Minimal disease in the sentinel lymph node: How to best measure sentinel node micrometastases to predict risk of additional non-sentinel lymph node disease

Annals of Surgical Oncology

Volumn 17, Issue 11, 2010, Pages 2909-2919

  Kumar, Shicha ^a   Bramlage, Matthew ^a   Jacks, Lindsay M ^a   Goldberg, Jessica I ^a   Patil, Sujata M ^a   Giri, Dilip D ^a   Van Zee, Kimberly J ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EOSIN; HEMATOXYLIN;

ADULT; AGED; ARTICLE; AXILLARY LYMPH NODE; BREAST CANCER; CANCER DIAGNOSIS; CANCER INVASION; CELL COUNT; CHI SQUARE TEST; COHORT ANALYSIS; FEMALE; FROZEN SECTION; HUMAN; IMMUNOHISTOCHEMISTRY; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; LYMPH VESSEL; LYMPHADENOPATHY; MAJOR CLINICAL STUDY; MICROMETASTASIS; MINIMAL RESIDUAL DISEASE; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; RISK; SENTINEL LYMPH NODE;

AXILLA; BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; CARCINOMA, LOBULAR; FEMALE; HUMANS; LYMPH NODES; LYMPHATIC METASTASIS; NEOPLASM, RESIDUAL; PREDICTIVE VALUE OF TESTS; PROGNOSIS; RETROSPECTIVE STUDIES; RISK ASSESSMENT; SENTINEL LYMPH NODE BIOPSY;

EID: 78049465550     PISSN: 10689265     EISSN: 15344681     Source Type: Journal    
DOI: 10.1245/s10434-010-1115-z     Document Type: Article

References (78)

1. AE Giuliano RC Jones M Brennan R Statman 1997 Sentinel lymphadenectomy in breast cancer J Clin Oncol 15 2345 2350 9196149
2. KU Chu RR Turner NM Hansen, et al. 1999 Do all patients with sentinel node metastasis from breast carcinoma need complete axillary node dissection? Ann Surg 229 536 541 10.1097/00000658-199904000-00013 10203087 (Pubitemid 30191752)
3. C Reynolds R Mick JH Donohue, et al. 1999 Sentinel lymph node biopsy with metastasis: can axillary dissection be avoided in some patients with breast cancer? J Clin Oncol 17 1720 1726 10561208
4. S Teng E Dupont C McCann, et al. 2000 Do cytokeratin-positive-only sentinel lymph nodes warrant complete axillary lymph node dissection in patients with invasive breast cancer? Am Surg 66 574 578 10888134
5. RR Turner KU Chu K Qi, et al. 2000 Pathologic features associated with nonsentinel lymph node metastases in patients with metastatic breast carcinoma in a sentinel lymph node Cancer 89 574 581 10.1002/1097-0142(20000801)89: 3<574::AID-CNCR12>3.0.CO;2-Y 10931456 (Pubitemid 30640103)
6. SF Abdessalam EE Zervos M Prasad, et al. 2001 Predictors of positive axillary lymph nodes after sentinel lymph node biopsy in breast cancer Am J Surg 182 316 320 10.1016/S0002-9610(01)00719-X 11720662 (Pubitemid 33079078)
7. VJ Kamath R Giuliano EL Dauway, et al. 2001 Characteristics of the sentinel lymph node in breast cancer predict further involvement of higher-echelon nodes in the axilla: a study to evaluate the need for complete axillary lymph node dissection Arch Surg 136 688 692 10.1001/archsurg.136.6.688 11387010
8. FD Rahusen H Torrenga PJ van Diest, et al. 2001 Predictive factors for metastatic involvement of nonsentinel nodes in patients with breast cancer Arch Surg 136 1059 1063 10.1001/archsurg.136.9.1059 11529831
9. G Viale E Maiorano G Mazzarol, et al. 2001 Histologic detection and clinical implications of micrometastases in axillary sentinel lymph nodes for patients with breast carcinoma Cancer 92 1378 1384 10.1002/1097-0142(20010915) 92:6<1378::AID-CNCR1460>3.0.CO;2-Y 11745213 (Pubitemid 32947820)
10. MR Weiser LL Montgomery LK Tan, et al. 2001 Lymphovascular invasion enhances the prediction of non-sentinel node metastases in breast cancer patients with positive sentinel nodes Ann Surg Oncol 8 145 149 10.1007/s10434-001-0145-y 11258779
11. U Sachdev K Murphy A Derzie, et al. 2002 Predictors of nonsentinel lymph node metastasis in breast cancer patients Am J Surg 183 213 217 10.1016/S0002-9610(02)00794-8 11943113 (Pubitemid 34273972)
12. CE Cox JV Kiluk AI Riker, et al. 2008 Significance of sentinel lymph node micrometastases in human breast cancer J Am Coll Surg 206 261 268 10.1016/j.jamcollsurg.2007.08.024 18222378
13. KJ Van Zee DM Manasseh JL Bevilacqua, et al. 2003 A nomogram for predicting the likelihood of additional nodal metastases in breast cancer patients with a positive sentinel node biopsy Ann Surg Oncol 10 1140 1151 10.1245/ASO.2003.03.015 14654469 (Pubitemid 40486808)
14. RF Hwang S Krishnamurthy KK Hunt, et al. 2003 Clinicopathologic factors predicting involvement of nonsentinel axillary nodes in women with breast cancer Ann Surg Oncol 10 248 254 10.1245/ASO.2003.05.020 12679309 (Pubitemid 40486957)
15. RF Saidi PS Dudrick SG Remine VK Mittal 2004 Nonsentinel lymph node status after positive sentinel lymph node biopsy in early breast cancer Am Surg 70 101 105 15011910
16. E Barranger C Coutant A Flahault, et al. 2005 An axilla scoring system to predict non-sentinel lymph node status in breast cancer patients with sentinel lymph node involvement Breast Cancer Res Treat 91 113 119 10.1007/s10549-004- 5781-z 15868438 (Pubitemid 40684923)
17. AC Degnim C Reynolds G Pantvaidya, et al. 2005 Nonsentinel node metastasis in breast cancer patients: assessment of an existing and a new predictive nomogram Am J Surg 190 543 550 10.1016/j.amjsurg.2005.06.008 16164917 (Pubitemid 41306072)
18. G Viale E Maiorano G Pruneri, et al. 2005 Predicting the risk for additional axillary metastases in patients with breast carcinoma and positive sentinel lymph node biopsy Ann Surg 241 319 325 10.1097/01.sla.0000150255.30665. 52 15650643
19. A Pal E Provenzano SW Duffy SE Pinder AD Purushotham 2008 A model for predicting non-sentinel lymph node metastatic disease when the sentinel lymph node is positive Br J Surg 95 302 309 10.1002/bjs.5943 17876750
20. HE Kohrt RA Olshen HR Bermas, et al. 2008 New models and online calculator for predicting non-sentinel lymph node status in sentinel lymph node positive breast cancer patients BMC Cancer 8 66 10.1186/1471-2407-8-66 18315887 (Pubitemid 351566658)
21. G Houvenaeghel C Nos S Giard, et al. 2009 A nomogram predictive of non-sentinel lymph node involvement in breast cancer patients with a sentinel lymph node micrometastasis Eur J Surg Oncol 35 690 695 19046847
22. Greene FL, Page DL, Fleming ID, et al. Breast. In: Greene FL, Page DL, Fleming ID, et al, eds. AJCC cancer staging manual, 6th ed. New York: Springer, 2002:221-40.
23. SL Wong MJ Edwards C Chao, et al. 2001 Predicting the status of the nonsentinel axillary nodes: a multicenter study Arch Surg 136 563 568 10.1001/archsurg.136.5.563 11343548
24. H Mignotte I Treilleux C Faure K Nessah A Bremond 2002 Axillary lymph-node dissection for positive sentinel nodes in breast cancer patients Eur J Surg Oncol 28 623 626 10.1053/ejso.2002.1272 12359198
25. JW Jakub NM Diaz MD Ebert, et al. 2002 Completion axillary lymph node dissection minimizes the likelihood of false negatives for patients with invasive breast carcinoma and cytokeratin positive only sentinel lymph nodes Am J Surg 184 302 306 10.1016/S0002-9610(02)00958-3 12383888 (Pubitemid 35287346)
26. LK Tan D Giri AJ Hummer, et al. 2008 Occult axillary node metastases in breast cancer are prognostically significant: results in 368 node-negative patients with 20-year follow-up J Clin Oncol 26 1803 1809 10.1200/JCO.2007.12. 6425 18332473
27. F Meric TA Buchholz NQ Mirza, et al. 2002 Long-term complications associated with breast-conservation surgery and radiotherapy Ann Surg Oncol 9 543 549 10.1007/BF02573889 12095969
28. CA Roberts PD Beitsch CE Litz, et al. 2003 Interpretive disparity among pathologists in breast sentinel lymph node evaluation Am J Surg 186 324 329 10.1016/S0002-9610(03)00268-X 14553843 (Pubitemid 38368603)
29. G Cserni I Amendoeira N Apostolikas, et al. 2004 Discrepancies in current practice of pathological evaluation of sentinel lymph nodes in breast cancer. Results of a questionnaire based survey by the European Working Group for Breast Screening Pathology J Clin Pathol 57 695 701 10.1136/jcp.2003.013599 15220360 (Pubitemid 38901482)
30. G Cserni S Bianchi W Boecker, et al. 2005 Improving the reproducibility of diagnosing micrometastases and isolated tumor cells Cancer 103 358 367 10.1002/cncr.20760 15593354 (Pubitemid 40129296)
31. RR Turner DL Weaver G Cserni, et al. 2008 Nodal stage classification for breast carcinoma: improving interobserver reproducibility through standardized histologic criteria and image-based training J Clin Oncol 26 258 263 10.1200/JCO.2007.13.0179 18182666
32. Edge SB, Byrd DR, Compton CC, et al. AJCC cancer staging manual, 7th ed. New York: Springer, 2010.
33. National Comprehensive Cancer Network. NCCN clinical practice guidelines in oncology for treatment of cancer by site: breast cancer. 2010. Available at: http://www.nccn.org/professionals/physician-gls/f-guidelines.asp.
34. J Park JV Fey AM Naik, et al. 2007 A declining rate of completion axillary dissection in sentinel lymph node-positive breast cancer patients is associated with the use of a multivariate nomogram Ann Surg 245 462 468 10.1097/01.sla.0000250439.86020.85 17435554 (Pubitemid 46673143)
35. KY Bilimoria DJ Bentrem NM Hansen, et al. 2009 Comparison of sentinel lymph node biopsy alone and completion axillary lymph node dissection for node-positive breast cancer J Clin Oncol 27 2946 2953 10.1200/JCO.2008.19.5750 19364968
36. G Cserni D Gregori F Merletti, et al. 2004 Meta-analysis of non-sentinel node metastases associated with micrometastatic sentinel nodes in breast cancer Br J Surg 91 1245 1252 10.1002/bjs.4725 15376203 (Pubitemid 39331448)
37. CH van Deurzen M de Boer EM Monninkhof, et al. 2008 Non-sentinel lymph node metastases associated with isolated breast cancer cells in the sentinel node J Natl Cancer Inst 100 1574 1580 10.1093/jnci/djn343 19001602
38. HS Cody III PI Borgen 1999 State-of-the-art approaches to sentinel node biopsy for breast cancer: study design, patient selection, technique, and quality control at Memorial Sloan-Kettering Cancer Center Surg Oncol 8 85 91 10.1016/S0960-7404(99)00029-8 10732960 (Pubitemid 30224701)
39. ML Smidt DM Kuster GJ van der Wilt FB Thunnissen KJ Van Zee LJ Strobbe 2005 Can the Memorial Sloan-Kettering Cancer Center nomogram predict the likelihood of nonsentinel lymph node metastases in breast cancer patients in the Netherlands? Ann Surg Oncol 12 1066 1072 10.1245/ASO.2005.07.022 16244802 (Pubitemid 41660683)
40. NK Soni HL Carmalt DJ Gillett AJ Spillane 2005 Evaluation of a breast cancer nomogram for prediction of non-sentinel lymph node positivity Eur J Surg Oncol 31 958 964 10.1016/j.ejso.2005.04.011 15979270 (Pubitemid 41671108)
41. LA Lambert GD Ayers RF Hwang, et al. 2006 Validation of a breast cancer nomogram for predicting nonsentinel lymph node metastases after a positive sentinel node biopsy Ann Surg Oncol 13 310 320 10.1245/ASO.2006.03.078 16463073 (Pubitemid 43255913)
42. MH Cripe LC Beran WC Liang BJ Sickle-Santanello 2006 The likelihood of additional nodal disease following a positive sentinel lymph node biopsy in breast cancer patients: validation of a nomogram Am J Surg 192 484 487 10.1016/j.amjsurg.2006.06.016 16978955 (Pubitemid 44344193)
43. S Alran Y De Rycke V Fourchotte, et al. 2007 Validation and limitations of use of a breast cancer nomogram predicting the likelihood of non-sentinel node involvement after positive sentinel node biopsy Ann Surg Oncol 14 2195 2201 10.1245/s10434-006-9331-2 17294071 (Pubitemid 47174905)
44. G Cserni 2007 Comparison of different validation studies on the use of the Memorial-Sloan Kettering Cancer Center nomogram predicting nonsentinel node involvement in sentinel node-positive breast cancer patients Am J Surg 194 699 700 10.1016/j.amjsurg.2006.11.035 17936439 (Pubitemid 47538457)
45. CE Dauphine JS Haukoos MP Vargas, et al. 2007 Evaluation of three scoring systems predicting non sentinel node metastasis in breast cancer patients with a positive sentinel node biopsy Ann Surg Oncol 14 1014 1019 10.1245/s10434-006- 9223-5 17176986
46. R Ponzone F Maggiorotto L Mariani, et al. 2007 Comparison of two models for the prediction of nonsentinel node metastases in breast cancer Am J Surg 193 686 692 10.1016/j.amjsurg.2006.09.031 17512277 (Pubitemid 46745283)
47. J Zgajnar A Perhavec M Hocevar, et al. 2007 Low performance of the MSKCC nomogram in preoperatively ultrasonically negative axillary lymph node in breast cancer patients J Surg Oncol 96 547 553 10.1002/jso.20835 17708546 (Pubitemid 350191478)
48. M Klar A Jochmann M Foeldi, et al. 2008 The MSKCC nomogram for prediction the likelihood of non-sentinel node involvement in a German breast cancer population Breast Cancer Res Treat 112 523 531 10.1007/s10549-007-9884-1 18172758
49. E Poirier L Sideris P Dube P Drolet SH Meterissian 2008 Analysis of clinical applicability of the breast cancer nomogram for positive sentinel lymph node: the Canadian experience Ann Surg Oncol 15 2562 2567 10.1245/s10434-008- 0033-9 18618183
50. B Unal AS Gur O Kayiran, et al. 2008 Models for predicting non-sentinel lymph node positivity in sentinel node positive breast cancer: the importance of scoring system Int J Clin Pract 62 1785 1791 10.1111/j.1742-1241.2008.01887.x 19143863
51. C Amanti A Lombardi S Maggi, et al. 2009 Is complete axillary dissection necessary for all patients with positive findings on sentinel lymph node biopsy? Validation of a breast cancer nomogram for predicting the likelihood of a non-sentinel lymph node Tumori 95 153 155 19579859
52. O Coufal T Pavlik P Fabian, et al. 2009 Predicting non-sentinel lymph node status after positive sentinel biopsy in breast cancer: what model performs the best in a Czech population? Pathol Oncol Res 15 733 740 10.1007/s12253-009-9177-6 19440855
53. C Coutant C Olivier E Lambaudie, et al. 2009 Comparison of models to predict nonsentinel lymph node status in breast cancer patients with metastatic sentinel lymph nodes: a prospective multicenter study J Clin Oncol 27 2800 2808 10.1200/JCO.2008.19.7418 19349546
54. R Ramjeesingh ML Quan S Gardner CM Holloway 2009 Prediction of involvement of sentinel and nonsentinel lymph nodes in a Canadian population with breast cancer Can J Surg 52 23 30 19234648
55. RF van la Parra MF Ernst JL Bevilacqua, et al. 2009 Validation of a nomogram to predict the risk of nonsentinel lymph node metastases in breast cancer patients with a positive sentinel node biopsy: validation of the MSKCC breast nomogram Ann Surg Oncol 16 1128 1135 10.1245/s10434-009-0359-y
56. K Dowlatshahi M Fan KJ Bloom, et al. 1999 Occult metastases in the sentinel lymph nodes of patients with early stage breast carcinoma: a preliminary study Cancer 86 990 996 10.1002/(SICI)1097-0142(19990915)86: 6<990::AID-CNCR14>3.0.CO;2-D 10491525 (Pubitemid 29439853)
57. G Houvenaeghel C Nos H Mignotte, et al. 2006 Micrometastases in sentinel lymph node in a multicentric study: predictive factors of nonsentinel lymph node involvement-Groupe des Chirurgiens de la Federation des Centres de Lutte Contre le Cancer J Clin Oncol 24 1814 1822 10.1200/JCO.2005.03.3225 16567771 (Pubitemid 46638978)
58. HSI Cody 2009 How do we evaluate sentinel nodes and interpret the findings? Curr Breast Cancer Rep 1 12 20 10.1007/s12609-009-0003-7
59. G Cserni S Bianchi V Vezzosi, et al. 2008 Variations in sentinel node isolated tumour cells/micrometastasis and non-sentinel node involvement rates according to different interpretations of the TNM definitions Eur J Cancer 44 2185 2191 10.1016/j.ejca.2008.06.033 18691877
60. B Rockhill D Spiegelman C Byrne DJ Hunter GA Colditz 2001 Validation of the Gail et al. model of breast cancer risk prediction and implications for chemoprevention J Natl Cancer Inst 93 358 366 10.1093/jnci/93.5.358 11238697
61. MF Brennan MW Kattan D Klimstra K Conlon 2004 Prognostic nomogram for patients undergoing resection for adenocarcinoma of the pancreas Ann Surg 240 293 298 10.1097/01.sla.0000133125.85489.07 15273554 (Pubitemid 38963021)
62. LJ Goldstein R Gray S Badve, et al. 2008 Prognostic utility of the 21-gene assay in hormone receptor-positive operable breast cancer compared with classical clinicopathologic features J Clin Oncol 26 4063 4071 10.1200/JCO.2007.14.4501 18678838
63. MW Kattan M Gonen WR Jarnagin, et al. 2008 A nomogram for predicting disease-specific survival after hepatic resection for metastatic colorectal cancer Ann Surg 247 282 287 10.1097/SLA.0b013e31815ed67b 18216534 (Pubitemid 351156771)
64. S Mook MK Schmidt EJ Rutgers, et al. 2009 Calibration and discriminatory accuracy of prognosis calculation for breast cancer with the online Adjuvant! program: a hospital-based retrospective cohort study Lancet Oncol 10 1070 1076 10.1016/S1470-2045(09)70254-2 19801202
65. MC Specht MW Kattan M Gonen J Fey KJ Van Zee 2005 Predicting nonsentinel node status after positive sentinel lymph biopsy for breast cancer: clinicians versus nomogram Ann Surg Oncol 12 654 659 10.1245/ASO.2005.06.037 16021535 (Pubitemid 41126095)
66. C Nos C Harding-MacKean P Freneaux, et al. 2003 Prediction of tumour involvement in remaining axillary lymph nodes when the sentinel node in a woman with breast cancer contains metastases Br J Surg 90 11 1354 1360 10.1002/bjs.4325 14598414 (Pubitemid 37421669)
67. DJ Dabbs M Fung D Landsittel K McManus R Johnson 2004 Sentinel lymph node micrometastasis as a predictor of axillary tumor burden Breast J 10 101 105 10.1111/j.1075-122X.2004.21280.x 15009035 (Pubitemid 38375029)
68. FJ Fleming D Kavanagh TB Crotty, et al. 2004 Factors affecting metastases to non-sentinel lymph nodes in breast cancer J Clin Pathol 57 73 76 10.1136/jcp.57.1.73 14693840 (Pubitemid 38091315)
69. TS Menes PI Tartter H Mizrachi, et al. 2005 Breast cancer patients with pN0(i+) and pN1(mi) sentinel nodes have high rate of nonsentinel node metastases J Am Coll Surg 200 323 327 10.1016/j.jamcollsurg.2004.10.022 15737841 (Pubitemid 40298965)
70. M Gipponi G Canavese R Lionetto, et al. 2006 The role of axillary lymph node dissection in breast cancer patients with sentinel lymph node micrometastases Eur J Surg Oncol 32 143 147 10.1016/j.ejso.2005.10.003 16300921 (Pubitemid 43257113)
71. A Katz A Niemierko I Gage, et al. 2006 Can axillary dissection be avoided in patients with sentinel lymph node metastasis? J Surg Oncol 93 550 558 10.1002/jso.20514 16705723 (Pubitemid 43806990)
72. MC van Rijk JL Peterse OE Nieweg, et al. 2006 Additional axillary metastases and stage migration in breast cancer patients with micrometastases or submicrometastases in sentinel lymph nodes Cancer 107 467 471 10.1002/cncr.22069 16804924 (Pubitemid 44107205)
73. J Reed M Rosman KM Verbanac, et al. 2009 Prognostic implications of isolated tumor cells and micrometastases in sentinel nodes of patients with invasive breast cancer: 10-year analysis of patients enrolled in the prospective East Carolina University/Anne Arundel Medical Center Sentinel Node Multicenter Study J Am Coll Surg 208 333 340 10.1016/j.jamcollsurg.2008.10.036 19317993
74. M Clarke R Collins S Darby, et al. 2005 Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trials Lancet 366 9503 2087 2106 16360786
75. AM Naik J Fey M Gemignani, et al. 2004 The risk of axillary relapse after sentinel lymph node biopsy for breast cancer is comparable with that of axillary lymph node dissection: a follow-up study of 4008 procedures Ann Surg 240 462 468 10.1097/01.sla.0000137130.23530.19 15319717 (Pubitemid 39121340)
76. V Galimberti 2006 International Breast Cancer Study Group trial of sentinel node biopsy J Clin Oncol 24 210 211 10.1200/JCO.2005.04.5658 16382130 (Pubitemid 46630516)
77. JA Olson Jr LM McCall P Beitsch, et al. 2008 Impact of immediate versus delayed axillary node dissection on surgical outcomes in breast cancer patients with positive sentinel nodes: results from American College of Surgeons Oncology Group trials Z0010 and Z0011 J Clin Oncol 26 3530 3535 10.1200/JCO.2007.15.5630 18640934
78. EJ Rutgers P Meijnen H Bonnefoi 2004 Clinical trials update of the European Organization for Research and Treatment of Cancer Breast Cancer Group Breast Cancer Res 6 165 169 10.1186/bcr906 15217489 (Pubitemid 39136485)